DURHAM, N.C., Sept. 28, 2026 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the addition of life science industry veterans Scott Coward and Paul Kuznik to the Company’s Board of…
Latest News
Editor' Pick
The platform uses Nvidia’s OpenShell open-source software, which runs on the company’s…
Just In
Descrease article font size Increase article font size A New Brunswick community…
Canada News
Descrease article font size Increase article font size Toronto police have identified a second homicide victim who was found in a burnt-out vehicle last…
Lifestyle
Canadian cities like Lethbridge, Alta., Saint John, N.B., and Thunder Bay, Ont., are some of the most affordable for those…
Tech & Innovation
Honor launches its new Magic 9 flagship phones in China today, and the 9 Pro Max features a design revamp, a capable camera, and a colossal…
Entertainment
Fifty years ago, a series of events on both sides of the…
